(Reuters) – European health regulator backed Merck & Co’s drug to treat a type of infection in adult kidney transplant recipients at high risk, the company said on Tuesday.
(Reporting by Pratik Jain in Bengaluru; Editing by Shilpi Majumdar)
EU regulator backs Merck’s viral infection drug
Oct 17, 2023 | 7:05 AM
